Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
Clinical trial NCT02620774 · COMPLETED
Trial details
- NCT number
- NCT02620774
- Sponsor
- Hartford Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-19
- Primary completion
- 2017-04-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.